Article
Dissecting the genomic complexity underlying medulloblastoma.
Nature - 2 Aug 2012
Jones David T W, Jäger Natalie, Kool Marcel, Zichner Thomas, Hutter Barbara, Sultan Marc, Cho Yoon-Jae, Pugh Trevor J, Hovestadt Volker, Stütz Adrian M, Rausch Tobias, Warnatz Hans-Jörg, Ryzhova Marina, Bender Sebastian, Sturm Dominik, Pleier Sabrina, Cin Huriye, Pfaff Elke, Sieber Laura, Wittmann Andrea, Remke Marc, Witt Hendrik, Hutter Sonja, Tzaridis Theophilos, Weischenfeldt Joachim, Raeder Benjamin, Avci Meryem, Amstislavskiy Vyacheslav, Zapatka Marc, Weber Ursula D, Wang Qi, Lasitschka Bärbel, Bartholomae Cynthia C, Schmidt Manfred, von Kalle Christof, Ast Volker, Lawerenz Chris, Eils Jürgen, Kabbe Rolf, Benes Vladimir, van Sluis Peter, Koster Jan, Volckmann Richard, Shih David, Betts Matthew J, Russell Robert B, Coco Simona, Tonini Gian Paolo, Schüller Ulrich, Hans Volkmar, Graf Norbert, Kim Yoo-Jin, Monoranu Camelia, Roggendorf Wolfgang, Unterberg Andreas, Herold-Mende Christel, Milde Till, Kulozik Andreas E, von Deimling Andreas, Witt Olaf, Maass Eberhard, Rössler Jochen, Ebinger Martin, Schuhmann Martin U, Frühwald Michael C, Hasselblatt Martin, Jabado Nada, Rutkowski Stefan, von Bueren André O, Williamson Dan, Clifford Steven C, McCabe Martin G, Collins V Peter, Wolf Stephan, Wiemann Stefan, Lehrach Hans, Brors Benedikt, Scheurlen Wolfram, Felsberg Jörg, Reifenberger Guido, Northcott Paul A, Taylor Michael D, Meyerson Matthew, Pomeroy Scott L, Yaspo Marie-Laure, Korbel Jan O, Korshunov Andrey, Eils Roland, Pfister Stefan M, Lichter Peter
Abstract excerpt
Medulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. It is the most common malignant brain tumour in children, and shows tremendous biological and clinical heterogeneity. Despite recent treatment advances, approximately 40% of children experience tumour recurrence, and 30% will die from their disease. Those who survive often have a significantly reduced quality of...
Read the complete abstract on PubMed